OOIR: Observatory of International Research

Papers

(The H4-Index of Clinical Kidney Journal is 32. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Prolonged normothermic perfusion: a promising approach to kidney transplantation	183
A puzzling renal Fanconi syndrome	90
Donor-derived membranous nephropathy	76
Correction to: Accelerated versus watchful waiting strategy of kidney replacement therapy for acute kidney injury: a systematic review and meta-analysis of randomized clinical trials	70
Risk factors for acute kidney injury and kidney relapse in patients with lupus podocytopathy	58
ECOSBot: a multicenter validation pilot study of a generative AI tool for OSCE-based nephrology training	57
But how green is it actually? Calculating the environmental footprint of kidney care environmental optimizations within haemodialysis	55
Impact of the COVID pandemic on vascular access creation for haemodialysis in 16 Spanish haemodialysis centres	54
Toward acid- and heparin-free dialysis: the regional anticoagulation approach	52
Circulating miR-129-3p in combination with clinical factors predicts vascular calcification in hemodialysis patients	46
Differentiating primary and secondary FSGS using non-invasive urine biomarkers	46
Bilateral nephrectomy in autosomal dominant polycystic kidney disease patients before or after renal transplantation: data from a retrospective cohort study	44
Association between frailty and bone health in early-stage chronic kidney disease: a study from the population-based CARTaGENE cohort	43
Correction to: Recognition of intraglomerular histological features with deep learning in protocol transplant biopsies and their association with kidney function and prognosis	43
Performance of the race-free CKD-EPI creatinine-based eGFR equation in a Danish cohort with measured GFR	40
Can exercise improve outcomes for frail haemodialysis patients?	40
Causal relationships between immune cell phenotypes and primary glomerular diseases: genetic evidence from bidirectional Mendelian randomization study	39
Cerebral blood flow following successful living kidney transplantation: the VINTAGE study	38
Non-invasive assessment of IgA nephropathy severity with [18F]AlF-NOTA-FAPI-04 PET/CT imaging	38
Plant-based diets for CKD patients: fascinating, trendy, but feasible? A green nephrology perspective	37
The “Leicester, Leicestershire, and RUtland Chronic Kidney Disease Integrated Care Delivery Project” (LUCID) programme update: the impact on novel kidney therapies	37
Risk factors for steroid-induced osteonecrosis of the femoral head in children with immune kidney disease	37
Clinically meaningful eGFR slope as a surrogate endpoint differs across CKD stages and slope evaluation periods: the CKD-JAC study	36
Making Use of Avacopan in Clinical Practice	36
Ten tips on performing economic evaluation in kidney disease	36

Galectin-3 as a prognostic biomarker in haemodialysis patients with preserved or mildly reduced ejection fraction	36
Machine learning models for predicting acute kidney injury: a systematic review and critical appraisal	35
Novel eGFR equations and cardiovascular outcomes in a multiethnic Asian cohort	35
Microvascular perfusion, perfused boundary region and glycocalyx shedding in patients with autosomal dominant polycystic kidney disease: results from the GlycoScore III study	34
Biomarkers in clinical epidemiology studies	33
Probability of chronic kidney disease and associated risk factors in Chinese adults: a cross-sectional study of 9 million Chinese adults in the Meinian Onehealth screening survey	33
Complement activation in anti-glomerular basement membrane disease before and after treatment with imlifidase	32
Alleviating symptoms in patients undergoing long-term hemodialysis: a focus on chronic kidney disease-associated pruritus	32
Meet and greet but avoid the heat: a reflection on the carbon footprint of congresses prompted by ERA2023	32
The spectrum of diseases, genetic landscape and new mutation sites of hereditary cystic kidney disease	32